Vasundhara Rasy. — 360° view

Vasundhara Rasy, a company in the Pharmaceuticals industry, reported revenue of ₹4.04 crore and net profit of ₹0.04 crore for the September 2026 quarter.

Vasundhara Rasy. (BSE: VRL) closed at ₹117.95 on 20 Nov 2026, down 44.6% over the past year. Its market capitalisation is ₹37 crore and it trades at 9.6 times earnings.

Share price
₹117.95 (20 Nov 2026)
Market cap
₹37 Cr (20 Nov 2026)
P/E
9.63 (20 Nov 2026)
Revenue
₹4 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
20.2% (FY26)
ROE
15.2% (FY26)
Book value
₹136 (FY26)
Dividend yield
1.70% (FY26)
52-week high / low
₹218.00 / ₹100.10 (20 Nov 2026)
1-year return
-44.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: VRL

Incorporated in 1987, Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.